 |
|
|
|
 |
|
|
| Article 1 to 10 out of 11 concerning Pall Corporation
|
-
Pall Opens New Centre of Excellence in India to Serve Fast-Growing Life Sciences Market
(05/21/2007)
As part of its global initiative to align with customers worldwide, Pall Corporation inaugurated its newest Life Sciences Centre of Excellence in Bangalore, India. The Centre shall drive process optimization innovations for the global life sciences ...
-
Pall Files Patent Infringement Suit Against BioQuate
(03/20/2007)
Pall Corporation filed a patent infringement action in the United States District Court for the Eastern District of Pennsylvania against BioQuate, Inc., based in Clearwater, Florida. The suit alleges that BioQuate is manufacturing and selling ...
-
First FDA Clearance of Sterile Field Cord Blood Collection Bag
(04/27/2006)
ViaCell and Pall Announce Collaborative Agreement
ViaCell, Inc. and Pall Corporation announced the first U.S. Food and Drug Administration clearance of a cord blood collection bag suitable for use in a sterile field. Pall and ViaCell collaborated on the development and design of the new collection ...
-
Pall Systems Play Key Role in Landmark NIH Study on Cord Blood
(08/19/2005)
As cord blood increasingly takes front and center stage as a critical source of stem cells for transplants, it has driven the need for consistent quality standards to ensure the safety and efficacy of this life-saving therapy. The newly published ...
-
Pall Prion Removal Technology Presented to FDA Blood Products Advisory Committee
(03/22/2005)
Pall Corporation presented an overview of the latest research on its prion reduction technology as a new risk reduction measure to help prevent transfusion transmission of infectious prions that can cause vCJD. The Company expects to launch the new ...
-
Removing Prions from Blood using Pall Technology
(02/11/2005)
Assessing the risk of potential exposure to variant Creutzfeldt-Jakob Disease (vCJD) from blood transfusion was the focus of the Food & Drug Administration (FDA) Transmissible Spongiform Encephalopathies (TSEs) Advisory Committee in Silver Spring, ...
-
Pall Opens Proteomics Service Centers to Optimize Research and Manufacturing Efficiency
(01/31/2005)
Pall Corporation launches a comprehensive line of chromatography sorbents. These advanced industry-proven sorbents from Pall greatly simplify protein separation and purification for biotechnology drug discovery, development and production. The ...
-
Pall Expands Line of Proteomics Technologies for Full Range of Drug Discovery and Development Solutions
(01/11/2005)
Opens Proteomics Service Centers to Optimize Research and Manufacturing Efficiency
Pall Corporation launches a comprehensive line of chromatography sorbents at PepTalk 2005. These advanced industry-proven sorbents from Pall greatly simplify protein separation and purification for biotechnology drug discovery, development and ...
-
Pall Acquires Chromatography Business from Ciphergen
(12/01/2004)
Pall Corporation announced that it has completed the acquisition of the BioSepra Process Division from Ciphergen Biosystems, Inc. The purchase price was $32 million, net of cash and debt. The BioSepra Process Division develops, manufactures and ...
-
Pall to Acquire Chromatography Business from Ciphergen Biosystems
(11/03/2004)
Pall Corporation announced it will acquire the BioSepra Process Division from Ciphergen Biosystems, Inc. (Nasdaq: CIPH - News) for a purchase price of approximately $32 million, net of cash and debt. The transaction is expected to close within 45 ...
|
|
|
|
|
Top